Labels for Safety, Visuals and Facility ID Desktop Printers
Labels for Product, Wire and Lab ID Benchtop Printers
Labels for Safety, Visuals and Facility ID Desktop Printers
Labels for Product, Wire and Lab ID Benchtop Printers
Safety and Facility ID Desktop Printers
Product, Wire and Lab ID Benchtop Printers
Barcode Scanners and RFID Readers
PaintStripe Floor Marking Stencils
Valve Lockouts & Hose Lockouts
Group Lock Boxes & Permit Control
Pipe Marker Accessories & Mounting Brackets
Maintenance and Production Tags
Calculators and Assessment Tools
Product Finders and Data Sheets
Brady Corporation
Quarter Ended
Sales for the fiscal 2013 second quarter ended
During the second quarter of fiscal 2013, the Company acquired
Net income (loss) in the fiscal 2013 second quarter was
Earnings (loss) per diluted Class A Common Share were
Six Months Ended
Sales for the six-month period ended
Net income (loss) for the six months ended
Earnings (loss) per diluted Class A Common Share were
Brady to Reorganize its Business:
Brady also reported that as part of its strategy to improve organic growth and profitability that it will be changing its organizational structure from geographically-based to an organization structured around three global business platforms: Identification Solutions, Workplace Safety and Die-Cut.
The Identification Solutions business will focus on innovative
identification solutions for a broad range of applications including
wire identification, product identification, safety and facility
identification and healthcare identification. The Workplace Safety
business will be expanding its multi-channel direct marketing model by
providing a broader set of workplace safety products with an increased
focus on e-business. The Die-Cut business will continue to provide
precision solutions primarily to the global electronics industry. Mr.
Commentary and Guidance:
“In the second quarter of fiscal 2013, we experienced slight organic
sales growth in the Americas and we experienced a 5.0 percent organic
sales decline in EMEA due to a challenging European economy. Our
performance in
Mr. Jaehnert continued, “We believe that our reorganization around
global business platforms will create better alignment of resources
required to deliver increasing levels of organic sales growth. We will
also be able to create a leaner, flatter organization that is closer to
the customer, allowing us to reduce costs by approximately
“We anticipate continuing pressure on organic sales for the remainder of
fiscal 2013 as the global macro-economy remains sluggish,” said Brady’s
Chief Financial Officer,
A webcast regarding Brady’s fiscal 2013 second quarter financial results
will be available at www.bradycorp.com
beginning at
* See accompanying notes for Non-GAAP measures.
In this news release, statements that are not reported financial results
or other historic information are “forward-looking statements.” These
forward-looking statements relate to, among other things, the Company’s
future financial position, business strategy, targets, projected sales,
costs, earnings, capital expenditures, debt levels and cash flows, and
plans and objectives of management for future operations. The use of
words such as “may,” “will,” “expect,” “intend,” “estimate,”
“anticipate,” “believe,” “should,” “project” or “plan” or similar
terminology are generally intended to identify forward-looking
statements. These forward-looking statements by their nature address
matters that are, to different degrees, uncertain and are subject to
risks, assumptions, and other factors, some of which are beyond Brady’s
control, that could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. For Brady,
uncertainties arise from: the length or severity of the current
worldwide economic downturn or timing or strength of a subsequent
recovery; increased usage of e-commerce allowing for ease of price
transparency; future financial performance of major markets Brady
serves, which include, without limitation, telecommunications, hard disk
drive, manufacturing, electrical, construction, laboratory, education,
governmental, public utility, computer, and transportation; future
competition; changes in the supply of, or price for, parts and
components; increased price pressure from suppliers and customers;
Brady’s ability to retain significant contracts and customers;
fluctuations in currency rates versus the U.S. dollar; risks associated
with international operations; difficulties associated with exports;
risks associated with obtaining governmental approvals and maintaining
regulatory compliance; Brady’s ability to develop and successfully
market new products; difficulties in making and integrating
acquisitions; risks associated with newly acquired businesses; risks
associated with restructuring plans; environmental, health and safety
compliance costs and liabilities; technology changes and potential
security violations to the Company’s information technology systems;
Brady’s ability to maintain compliance with its debt covenants; increase
in our level of debt; potential write-offs of Brady’s substantial
intangible assets; unforeseen tax consequences; and numerous other
matters of national, regional and global scale, including those of a
political, economic, business, competitive, and regulatory nature
contained from time to time in Brady’s
These uncertainties may cause Brady’s actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.
BRADY CORPORATION AND SUBSIDIARIES | ||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||
(Dollars in Thousands, Except Per Share Amounts) | ||||||||||||||||
(Unaudited) | (Unaudited) | |||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Net sales | $ | 324,182 | $ | 320,584 | $ | 661,828 | $ | 670,092 | ||||||||
Cost of products sold | 174,130 | 167,279 | 347,156 | 348,956 | ||||||||||||
Gross margin | 150,052 | 153,305 | 314,672 | 321,136 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development | 8,551 | 9,972 | 17,036 | 19,781 | ||||||||||||
Selling, general and administrative | 117,240 | 104,843 | 225,501 | 213,775 | ||||||||||||
Restructuring charges | 4,031 | — | 4,031 | — | ||||||||||||
Impairment charge | — | 115,688 | — | 115,688 | ||||||||||||
Non-routine items | (5,220 | ) | — | (1,782 | ) | — | ||||||||||
Total operating expenses | 124,602 | 230,503 | 244,786 | 349,244 | ||||||||||||
Operating income (loss) | 25,450 | (77,198 | ) | 69,886 | (28,108 | ) | ||||||||||
Other income and (expense): | ||||||||||||||||
Investment and other income (expense) | 897 | 812 | 1,294 | 610 | ||||||||||||
Interest expense | (4,406 | ) | (4,933 | ) | (8,569 | ) | (9,980 | ) | ||||||||
Income before income taxes | 21,941 | (81,319 | ) | 62,611 | (37,478 | ) | ||||||||||
Income taxes | 30,625 | 8,635 | 44,107 | 19,744 | ||||||||||||
Net (loss) income | $ | (8,684 | ) | $ | (89,954 | ) | $ | 18,504 | $ | (57,222 | ) | |||||
Per Class A Nonvoting Common Share: | ||||||||||||||||
Basic net income | $ | (0.17 | ) | $ | (1.72 | ) | $ | 0.36 | $ | (1.09 | ) | |||||
Diluted net income | $ | (0.17 | ) | $ | (1.72 | ) | $ | 0.36 | $ | (1.09 | ) | |||||
Dividends | $ | 0.19 | $ | 0.185 | $ | 0.38 | $ | 0.37 | ||||||||
Per Class B Voting Common Share: | ||||||||||||||||
Basic net income | $ | (0.17 | ) | $ | (1.72 | ) | $ | 0.34 | $ | (1.11 | ) | |||||
Diluted net income | $ | (0.17 | ) | $ | (1.72 | ) | $ | 0.34 | $ | (1.11 | ) | |||||
Dividends | $ | 0.19 | $ | 0.185 | $ | 0.36 | $ | 0.35 | ||||||||
Weighted average common shares outstanding (in thousands): | ||||||||||||||||
Basic | 51,177 | 52,447 | 51,108 | 52,552 | ||||||||||||
Diluted | 51,177 | 52,447 | 51,507 | 52,552 |
BRADY CORPORATION AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(Dollars in Thousands) | ||||||||
(Unaudited) | ||||||||
January 31, 2013 | July 31, 2012 | |||||||
ASSETS |
||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 141,311 | $ | 305,900 | ||||
Accounts receivable—net | 229,219 | 199,006 | ||||||
Inventories: | ||||||||
Finished products | 75,040 | 64,740 | ||||||
Work-in-process | 17,549 | 15,377 | ||||||
Raw materials and supplies | 32,242 | 25,407 | ||||||
Total inventories | 124,831 | 105,524 | ||||||
Prepaid expenses and other current assets | 47,656 | 40,424 | ||||||
Total current assets | 543,017 | 650,854 | ||||||
Other assets: | ||||||||
Goodwill | 877,972 | 676,791 | ||||||
Other intangible assets | 185,495 | 84,119 | ||||||
Deferred income taxes | 6,032 | 45,356 | ||||||
Other | 22,711 | 20,584 | ||||||
Property, plant and equipment: | ||||||||
Cost: | ||||||||
Land | 9,145 | 8,651 | ||||||
Buildings and improvements | 105,501 | 101,962 | ||||||
Machinery and equipment | 313,512 | 292,130 | ||||||
Construction in progress | 12,444 | 10,417 | ||||||
440,602 | 413,160 | |||||||
Less accumulated depreciation | 289,860 | 283,145 | ||||||
Property, plant and equipment—net | 150,742 | 130,015 | ||||||
Total | $ | 1,785,969 | $ | 1,607,719 | ||||
LIABILITIES AND STOCKHOLDERS’ INVESTMENT |
||||||||
Current liabilities: | ||||||||
Notes payable | $ | 112,340 | $ | — | ||||
Accounts payable | 103,197 | 86,646 | ||||||
Wages and amounts withheld from employees | 40,564 | 54,629 | ||||||
Taxes, other than income taxes | 8,313 | 9,307 | ||||||
Accrued income taxes | 8,869 | 14,357 | ||||||
Other current liabilities | 46,930 | 40,815 | ||||||
Current maturities on long-term debt | 61,264 | 61,264 | ||||||
Total current liabilities | 381,477 | 267,018 | ||||||
Long-term obligations, less current maturities | 264,417 | 254,944 | ||||||
Other liabilities | 102,225 | 76,404 | ||||||
Total liabilities | 748,119 | 598,366 | ||||||
Stockholders’ investment: | ||||||||
Common stock: | ||||||||
Class A nonvoting common stock—Issued 51,261,487 and 51,261,487 shares, respectively and outstanding 47,711,496 and 47,630,926 shares, respectively | 513 | 513 | ||||||
Class B voting common stock—Issued and outstanding, 3,538,628 shares | 35 | 35 | ||||||
Additional paid-in capital | 315,425 | 313,008 | ||||||
Earnings retained in the business | 731,294 | 732,290 | ||||||
Treasury stock—3,234,991 and 3,245,561 shares, respectively of Class A nonvoting common stock, at cost | (88,354 | ) | (92,600 | ) | ||||
Accumulated other comprehensive income | 81,475 | 59,411 | ||||||
Other | (2,538 | ) | (3,304 | ) | ||||
Total stockholders’ investment | 1,037,850 | 1,009,353 | ||||||
Total | $ | 1,785,969 | $ | 1,607,719 |
BRADY CORPORATION AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(Dollars in Thousands) | ||||||||
(Unaudited) | ||||||||
Six Months Ended January 31, | ||||||||
2013 | 2012 | |||||||
Operating activities: | ||||||||
Net income (loss) | $ | 18,504 | $ | (57,222 | ) | |||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 22,046 | 22,176 | ||||||
Non-cash portion of restructuring charges | 200 | — | ||||||
Non-cash portion of stock-based compensation expense | 6,868 | 5,506 | ||||||
Impairment charge | — | 115,688 | ||||||
Loss (gain) on sales of businesses | 3,138 | — | ||||||
Deferred income taxes | 26,050 | (4,831 | ) | |||||
Changes in operating assets and liabilities (net of effects of business acquisitions/divestitures): | ||||||||
Accounts receivable | (5,418 | ) | 6,029 | |||||
Inventories | (4,475 | ) | (11,814 | ) | ||||
Prepaid expenses and other assets | (2,772 | ) | (5,155 | ) | ||||
Accounts payable and accrued liabilities | (13,629 | ) | (36,297 | ) | ||||
Income taxes | (6,318 | ) | 9,221 | |||||
Net cash provided by operating activities | 44,194 | 43,301 | ||||||
Investing activities: | ||||||||
Purchases of property, plant and equipment | (15,667 | ) | (11,100 | ) | ||||
Payments of contingent consideration | — | (2,580 | ) | |||||
Settlement of net investment hedges | — | (797 | ) | |||||
Acquisition of business, net of cash acquired | (300,757 | ) | — | |||||
Sales of businesses, net of cash retained | 10,178 | — | ||||||
Other | (549 | ) | (128 | ) | ||||
Net cash used in investing activities | (306,795 | ) | (14,605 | ) | ||||
Financing activities: | ||||||||
Payment of dividends | (19,499 | ) | (19,452 | ) | ||||
Proceeds from issuance of common stock | 4,409 | 2,301 | ||||||
Purchase of treasury stock | (5,121 | ) | (12,309 | ) | ||||
Proceeds from borrowings on credit revolver | 220,000 | — | ||||||
Repayment of borrowings on credit revolver | (112,472 | ) | — | |||||
Income tax benefit from the exercise of stock options and deferred compensation distribution, and other | 1,273 | 566 | ||||||
Net cash provided by (used in) financing activities | 88,590 | (28,894 | ) | |||||
Effect of exchange rate changes on cash | 9,422 | (9,442 | ) | |||||
Net decrease in cash and cash equivalents | (164,589 | ) | (9,640 | ) | ||||
Cash and cash equivalents, beginning of period | 305,900 | 389,971 | ||||||
Cash and cash equivalents, end of period | $ | 141,311 | $ | 380,331 | ||||
Supplemental disclosures: | ||||||||
Cash paid during the period for: | ||||||||
Interest, net of capitalized interest | $ | 7,866 | $ | 9,521 | ||||
Income taxes, net of refunds | 19,964 | 16,189 | ||||||
Acquisitions: | ||||||||
Fair value of assets acquired, net of cash | $ | 168,675 | $ | — | ||||
Liabilities assumed | (57,860 | ) | — | |||||
Goodwill | 189,942 | — | ||||||
Net cash paid for acquisitions | $ | 300,757 | $ | — |
Information by regional segment for the three and six months ended January 31, 2013 and 2012 is as follows: | |||||||||||||||||||||||||
Corporate | |||||||||||||||||||||||||
and | |||||||||||||||||||||||||
(Dollars in Thousands) | Americas | EMEA | Asia-Pacific | Total Region | Eliminations | Total | |||||||||||||||||||
SALES TO EXTERNAL CUSTOMERS | |||||||||||||||||||||||||
Three months ended: | |||||||||||||||||||||||||
January 31, 2013 | $ | 147,716 | $ | 94,395 | $ | 82,071 | $ | 324,182 | — | $ | 324,182 | ||||||||||||||
January 31, 2012 | $ | 138,405 | $ | 95,593 | $ | 86,586 | $ | 320,584 | — | $ | 320,584 | ||||||||||||||
Six months ended: | |||||||||||||||||||||||||
January 31, 2013 | $ | 296,408 | $ | 187,628 | $ | 177,792 | $ | 661,828 | — | $ | 661,828 | ||||||||||||||
January 31, 2012 | $ | 292,267 | $ | 192,949 | $ | 184,876 | $ | 670,092 | — | $ | 670,092 | ||||||||||||||
SALES INFORMATION | |||||||||||||||||||||||||
Three months ended January 31, 2013: | |||||||||||||||||||||||||
Organic | 0.6 | % | (5.0 | )% | (7.0 | )% | (3.1 | )% | — | % | (3.1 | )% | |||||||||||||
Currency | (0.4 | )% | (0.3 | )% | 1.8 | % | 0.2 | % | — | % | 0.2 | % | |||||||||||||
Acquisitions/Divestitures | 6.5 | % | 4.0 | % | 0.0 | % | 4.0 | % | — | % | 4.0 | % | |||||||||||||
Total | 6.7 | % | (1.3 | )% | (5.2 | )% | 1.1 | % | — | % | 1.1 | % | |||||||||||||
Six months ended January 31, 2013: | |||||||||||||||||||||||||
Organic | (0.1 | )% | (4.1 | )% | (4.6 | )% | (2.5 | )% | — | % | (2.5 | )% | |||||||||||||
Currency | (0.8 | )% | (3.0 | )% | 0.8 | % | (1.0 | )% | — | % | (1.0 | )% | |||||||||||||
Acquisitions/Divestitures | 2.3 | % | 4.3 | % | 0.0 | % | 2.2 | % | — | % | 2.2 | % | |||||||||||||
Total | 1.4 | % | (2.8 | )% | (3.8 | )% | (1.3 | )% | — | % | (1.3 | )% | |||||||||||||
SEGMENT PROFIT | |||||||||||||||||||||||||
Three months ended: | |||||||||||||||||||||||||
January 31, 2013 | $ | 32,336 | $ | 23,723 | $ | 5,514 | $ | 61,573 | $ | (1,794 | ) | $ | 59,779 | ||||||||||||
January 31, 2012 | $ | 35,798 | $ | 26,562 | $ | 7,733 | $ | 70,093 | $ | (2,359 | ) | $ | 67,734 | ||||||||||||
Percentage change | (9.7 | )% | (10.7 | )% | (28.7 | )% | (12.2 | )% | (11.7 | )% | |||||||||||||||
Six months ended: | |||||||||||||||||||||||||
January 31, 2013 | $ | 76,969 | $ | 47,290 | $ | 17,569 | $ | 141,828 | $ | (3,767 | ) | $ | 138,061 | ||||||||||||
January 31, 2012 | $ | 79,028 | $ | 52,861 | $ | 21,037 | $ | 152,926 | $ | (5,622 | ) | $ | 147,304 | ||||||||||||
Percentage change | (2.6 | )% | (10.5 | )% | (16.5 | )% | (7.3 | )% | (6.3 | )% |
NET INCOME RECONCILIATION (in thousands) | ||||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | |||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Total profit for reportable segments | $ | 61,573 | $ | 70,093 | $ | 141,828 | $ | 152,926 | ||||||||
Corporate and eliminations | (1,794 | ) | (2,359 | ) | (3,767 | ) | (5,622 | ) | ||||||||
Unallocated amounts: | ||||||||||||||||
Administrative costs | (35,518 | ) | (29,244 | ) | (65,926 | ) | (59,724 | ) | ||||||||
Restructuring charges | (4,031 | ) | - | (4,031 | ) | - | ||||||||||
Impairment charge | - | (115,688 | ) | - | (115,688 | ) | ||||||||||
Non-routine items | 5,220 | - | 1,782 | - | ||||||||||||
Investment and other income | 897 | 812 | 1,294 | 610 | ||||||||||||
Interest expense | (4,406 | ) | (4,933 | ) | (8,569 | ) | (9,980 | ) | ||||||||
Income (loss) before income taxes | 21,941 | (81,319 | ) | 62,611 | (37,478 | ) | ||||||||||
Income taxes | 30,625 | 8,635 | 44,107 | 19,744 | ||||||||||||
Net (loss) income | $ | (8,684 | ) | $ | (89,954 | ) | $ | 18,504 | $ | (57,222 | ) |
GAAP TO NON-GAAP MEASURES | |||||||||||||||||||||||
(Dollars in Thousands, Except Per Share Amounts) | |||||||||||||||||||||||
In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure. | |||||||||||||||||||||||
EBITDA: | |||||||||||||||||||||||
Brady is presenting EBITDA because it is used by many of our investors and lenders, and is presented as a convenience to them. EBITDA represents net income before interest expense, income taxes, depreciation and amortization. EBITDA is not a calculation based on generally accepted accounting principles ("GAAP"). The amounts included in the EBITDA calculation, however, are derived from amounts included in the Condensed Consolidated Statements of Income data. EBITDA should not be considered as an alternative to net income or operating income as an indicator of the Company's operating performance, or as an alternative to operating cash flows as a measure of liquidity. The EBITDA measure presented may not always be comparable to similarly titled measures reported by other companies due to differences in the components of the calculation. | |||||||||||||||||||||||
Fiscal 2013 | |||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||
EBITDA: | |||||||||||||||||||||||
Net income (loss) | $ | 27,188 | $ | (8,684 | ) | $ | 18,504 | ||||||||||||||||
Interest expense | 4,163 | 4,406 | 8,569 | ||||||||||||||||||||
Income taxes | 13,482 | 30,625 | 44,107 | ||||||||||||||||||||
Depreciation and amortization | 10,675 | 11,371 | 22,046 | ||||||||||||||||||||
EBITDA (non-GAAP measure) | $ | 55,508 | $ | 37,718 | — | — | $ | 93,226 | |||||||||||||||
Fiscal 2012 | |||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Total | |||||||||||||||||||
EBITDA: | |||||||||||||||||||||||
Net income (loss) | $ | 32,732 | $ | (89,954 | ) | $ | 27,652 | $ | 11,659 | $ | (17,911 | ) | |||||||||||
Interest expense | 5,047 | 4,933 | 4,735 | 4,375 | 19,090 | ||||||||||||||||||
Income taxes | 11,109 | 8,635 | 9,676 | 11,241 | 40,661 | ||||||||||||||||||
Depreciation and amortization | 11,241 | 10,935 | 10,745 | 11,066 | 43,987 | ||||||||||||||||||
Impairment charge | — | 115,688 | — | — | 115,688 | ||||||||||||||||||
EBITDA (non-GAAP measure) | $ | 60,129 | $ | 50,237 | $ | 52,808 | $ | 38,341 | $ | 201,515 | |||||||||||||
GAAP TO NON-GAAP MEASURES | |||||||||||||||||||||||
(Dollars in Thousands, Except Per Share Amounts) | |||||||||||||||||||||||
Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Brady is presenting the Non-GAAP measure "Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Income (Loss) Before Taxes to Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | ||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||
Income (loss) before taxes (GAAP measure) | $ | 21,941 | $ | (81,319 | ) | $ | 62,611 | $ | (37,478 | ) | |||||||||||||
Non-routine items - pre-tax | |||||||||||||||||||||||
Gain on Thailand insurance recovery | (5,220 | ) | — | (5,220 | ) | — | |||||||||||||||||
Loss on the sale of Brady Medical | — | — | 3,675 | — | |||||||||||||||||||
Gain on the sale of Varitronics | — | — | (237 | ) | — | ||||||||||||||||||
Non-routine items - pre-tax | (5,220 | ) | — | (1,782 | ) | — | |||||||||||||||||
Other items - pre-tax | |||||||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Purchase accounting expense related to inventory | 1,530 | — | 1,530 | — | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||||||
PDC acquisition-related expenses | 3,600 | — | 3,600 | — | |||||||||||||||||||
Restructuring charges | 4,031 | — | 4,031 | — | |||||||||||||||||||
Impairment charge | — | 115,688 | — | 115,688 | |||||||||||||||||||
Income taxes | |||||||||||||||||||||||
Non-cash tax charge | — | — | — | — | |||||||||||||||||||
Other items - pre-tax | 9,161 | 115,688 | 9,161 | 115,688 | |||||||||||||||||||
Income Before Taxes Excluding Restructuring Charges, Non-Routine Items, and Other (Non-GAAP measure) |
$ | 25,882 | $ | 34,369 | $ | 69,990 | $ | 78,210 | |||||||||||||||
Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Brady is presenting the Non-GAAP measure "Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Income Taxes to Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | ||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||
Income taxes (GAAP measure) | $ | 30,625 | $ | 8,635 | $ | 44,107 | $ | 19,744 | |||||||||||||||
Non-routine items - tax effect | |||||||||||||||||||||||
Gain on Thailand insurance recovery | (1,201 | ) | — | (1,201 | ) | — | |||||||||||||||||
Loss on the sale of Brady Medical | — | — | 1,098 | — | |||||||||||||||||||
Gain on the sale of Varitronics | — | — | (875 | ) | — | ||||||||||||||||||
Non-routine items - tax effect | (1,201 | ) | — | (978 | ) | — | |||||||||||||||||
Other items - tax effect | |||||||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Purchase accounting expense related to inventory | 581 | — | 581 | — | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||||||
PDC acquisition-related expenses | 641 | — | 641 | — | |||||||||||||||||||
Restructuring charges | 750 | — | 750 | — | |||||||||||||||||||
Impairment charge | — | — | — | — | |||||||||||||||||||
Income taxes | |||||||||||||||||||||||
Non-cash tax charge | (25,000 | ) | — | (25,000 | ) | — | |||||||||||||||||
Other items - tax effect | (23,028 | ) | — | (23,028 | ) | — | |||||||||||||||||
Income Taxes Excluding Restructuring Charges, Non-Routine Items, and Other (Non-GAAP measure) |
$ | 6,396 | $ | 8,635 | $ | 20,101 | $ | 19,744 | |||||||||||||||
GAAP TO NON-GAAP MEASURES | |||||||||||||||||||||||
(Dollars in Thousands, Except Per Share Amounts) | |||||||||||||||||||||||
Net Income Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Brady is presenting the Non-GAAP measure "Net Income Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Net (Loss) Income to Net Income Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | ||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||
Net (loss) income (GAAP measure) | $ | (8,684 | ) | $ | (89,954 | ) | $ | 18,504 | $ | (57,222 | ) | ||||||||||||
Non-routine items - net of tax | |||||||||||||||||||||||
Gain on Thailand insurance recovery | (4,019 | ) | — | (4,019 | ) | — | |||||||||||||||||
Loss on the sale of Brady Medical | — | — | 2,577 | — | |||||||||||||||||||
Gain on the sale of Varitronics | — | — | 638 | — | |||||||||||||||||||
Non-routine items - net of tax | (4,019 | ) | — | (804 | ) | — | |||||||||||||||||
Other items - net of tax | |||||||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Purchase accounting expense related to inventory | 949 | — | 949 | — | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||||||
PDC acquisition-related expenses | 2,959 | — | 2,959 | — | |||||||||||||||||||
Restructuring charges | 3,281 | — | 3,281 | — | |||||||||||||||||||
Impairment charge | — | 115,688 | — | 115,688 | |||||||||||||||||||
Income taxes | |||||||||||||||||||||||
Non-cash tax charge | 25,000 | — | 25,000 | — | |||||||||||||||||||
Other items - net of tax | 32,189 | 115,688 | 32,189 | 115,688 | |||||||||||||||||||
Net Income Excluding Restructuring Charges, Non-Routine Items, and Other (Non-GAAP measure) |
$ | 19,486 | $ | 25,734 | $ | 49,889 | $ | 58,466 | |||||||||||||||
Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Brady is presenting the Non-GAAP measure "Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other." This is not a calculation based upon GAAP. The amounts included in this Non-GAAP measure are derived from amounts included in the Condensed Consolidated Statements of Income data. We do not view these items to be part of our sustainable results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of Diluted Net (Loss) Income Per Class A Nonvoting Common Share to Diluted Net Income Per Class A Nonvoting Common Share Excluding Restructuring Charges, Non-Routine Items, and Other: | |||||||||||||||||||||||
Three Months Ended January 31, | Six Months Ended January 31, | ||||||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||||
Diluted Net (Loss) Income Per Class A Nonvoting Share (GAAP measure) |
$ | (0.17 | ) | $ | (1.72 | ) | $ | 0.36 | $ | (1.09 | ) | ||||||||||||
Non-routine items | |||||||||||||||||||||||
Gain on Thailand insurance recovery | (0.08 | ) | — | (0.08 | ) | — | |||||||||||||||||
Loss on the sale of Brady Medical | — | — | 0.05 | — | |||||||||||||||||||
Gain on the sale of Varitronics | — | — | 0.01 | — | |||||||||||||||||||
Non-routine items | (0.08 | ) | — | (0.02 | ) | — | |||||||||||||||||
Other items | |||||||||||||||||||||||
Cost of goods sold | |||||||||||||||||||||||
Purchase accounting expense related to inventory | 0.02 | — | 0.02 | — | |||||||||||||||||||
Selling, general and administrative | |||||||||||||||||||||||
PDC acquisition-related expenses | 0.06 | — | 0.06 | — | |||||||||||||||||||
Restructuring charges | 0.06 | — | 0.06 | — | |||||||||||||||||||
Impairment charge | — | 2.21 | — | 2.21 | |||||||||||||||||||
Income taxes | |||||||||||||||||||||||
Non-cash tax charge | 0.49 | — | 0.49 | — | |||||||||||||||||||
Other items | 0.63 | 2.21 | 0.62 | 2.21 | |||||||||||||||||||
Diluted Net Income Per Class A Nonvoting Share Excluding Restructuring Charges, Non-Routine Items, and Other (Non-GAAP measure) |
$ | 0.38 | $ | 0.49 | $ | 0.97 | $ | 1.12 |
Source:
Brady Corporation
Investor contact:
Aaron Pearce 414-438-6895
or
Media
contact:
Carole Herbstreit 414-438-6882